Twist Bioscience Corp
NASDAQ:TWST

Watchlist Manager
Twist Bioscience Corp Logo
Twist Bioscience Corp
NASDAQ:TWST
Watchlist
Price: 42.6 USD 2.26% Market Closed
Market Cap: 2.5B USD
Have any thoughts about
Twist Bioscience Corp?
Write Note

Wall Street
Price Targets

TWST Price Targets Summary
Twist Bioscience Corp

Wall Street analysts forecast TWST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TWST is 54.25 USD with a low forecast of 48.38 USD and a high forecast of 65.1 USD.

Lowest
Price Target
48.38 USD
14% Upside
Average
Price Target
54.25 USD
27% Upside
Highest
Price Target
65.1 USD
53% Upside

TWST Last Price Targets
Twist Bioscience Corp

The latest public price target was made on Sep 17, 2024 by Catherine Schulte from Robert W. Baird , who expects TWST stock to rise by 8% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Catherine Schulte
Robert W. Baird
46 USD
Upside 8%
2 months ago
Sep 17, 2024
Baird Reiterates Outperform Rating on Twist Bioscience (TWST)
StreetInsider
Subbu Nambi
Guggenheim
53 USD
Upside 24%
5 months ago
Jun 5, 2024
Twist Bioscience initiated with a Buy at Guggenheim (yesterday)
TheFly
Catherine Ramsey Schulte
Robert W. Baird
40 USD
Downside 6%
6 months ago
May 3, 2024
Twist Bioscience price target raised to $40 from $39 at Baird
TheFly
Luke Sergott
Barclays
32 USD
Downside 25%
1 year ago
Feb 5, 2023
Twist Bioscience price target lowered to $32 from $37 at Barclays
TheFly
Catherine Schulte
Robert W. Baird
Price Target 46 USD
Upside/Downside 8%
View Source
Subbu Nambi
Guggenheim
Price Target 53 USD
Upside/Downside 24%
View Source
Catherine Ramsey Schulte
Robert W. Baird
Price Target 40 USD
Upside/Downside 6%
View Source
Luke Sergott
Barclays
Price Target 32 USD
Upside/Downside 25%
View Source
Twist Bioscience Corp Competitors:
Price Targets
EXAI
Exscientia PLC
13% Upside
CPRX
Catalyst Pharmaceuticals Inc
53% Upside
CTMX
CytomX Therapeutics Inc
509% Upside
ADVM
Adverum Biotechnologies Inc
437% Upside
214450
PharmaResearch Co Ltd
40% Upside
GILD
Gilead Sciences Inc
8% Upside
CRVO
Diffusion Pharmaceuticals Inc
513% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
145% Upside

Revenue
Forecast

Revenue Estimate
Twist Bioscience Corp

For the last 7 years the compound annual growth rate for Twist Bioscience Corp's revenue is 62%. The projected CAGR for the next 3 years is 19%.

62%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Twist Bioscience Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Twist Bioscience Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TWST's stock price target?
Price Target
54.25 USD

According to Wall Street analysts, the average 1-year price target for TWST is 54.25 USD with a low forecast of 48.38 USD and a high forecast of 65.1 USD.

What is Twist Bioscience Corp's Revenue forecast?
Projected CAGR
19%

For the last 7 years the compound annual growth rate for Twist Bioscience Corp's revenue is 62%. The projected CAGR for the next 3 years is 19%.

Back to Top